Increase in number of patients suffering from chronic diseases fuels the growth of the global carrier screening market.
The carrier screening market size was valued at $1,378.06 million in 2020, and is projected to reach $4,002.05 million by 2030, registering a CAGR of 11.5% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at:
https://www.alliedmarketresearch.com/request-sample/11636
Emphasis on early disease detection and prevention and technological advancements drive the growth of the global carrier screening market. However, lack of standard guidelines for carrier screening hinders the market growth. On the contrary, growing awareness of carrier screening would open new opportunities for the market players in the future.
- The Covid-19 outbreak encouraged pharmaceutical and biotechnology companies to join forces to develop vaccines and address the issues of medicine supply chain.
- The increased demand for management of Covid-19 increased the opportunities for carrier screen market.
The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on the carrier screening market. Pregnant or recently pregnant women with COVID-19 are more likely to be admitted to the intensive care unit or need respiratory support when compared with non-pregnant women of reproductive age. Pregnant women with COVID-19 were also more likely to give birth prematurely. For instance, as per the data published by the World Health Organization in 2020, 1 in 4 of all babies born to women with COVID-19 were admitted to a neonatal unit, but data on causes of preterm births or indications for admission to neonatal units among these babies is lacking. Stillbirth and newborn death rates however were low.
Based on type, the expanded carrier screening segment held the largest share in 2020, accounting for nearly two-thirds of the market. Moreover, the segment is expected to manifest the highest CAGR of 12.4% from 2021 to 2030. The report includes an analysis of the targeted disease carrier screening segments.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/11636
The global carrier screening market report includes an in-depth analysis of the prime market players such as Invitae, OPKO Health, Fulgent Genetics, Myriad Genetics, Sema4, Illumina, Eurofins Scientific, Thermo Fisher Scientific, and Quest Diagnostics.
Request Customization: https://www.alliedmarketresearch.com/request-for-customization/2046
Leading market players
- Abbott Laboratories
- Novartis AG
- Carl Zeiss Meditec AG
- Essilor International S.A.
- HAAG-Streit Holding AG
- Johnson & Johnson
- Nidek Co., Ltd.
- Topcon Corporation
- Valeant Pharmaceuticals International, Inc.
- Ziemer Ophthalmic Systems AG.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.